NO20003217D0 - Termodynamisk stabil form av (R)-3-[[(4-fluorfenyl)- sulfonyl]amino]-1,2,3,4-tetrahydro-9H-karbazol-9-propansyre - Google Patents
Termodynamisk stabil form av (R)-3-[[(4-fluorfenyl)- sulfonyl]amino]-1,2,3,4-tetrahydro-9H-karbazol-9-propansyreInfo
- Publication number
- NO20003217D0 NO20003217D0 NO20003217A NO20003217A NO20003217D0 NO 20003217 D0 NO20003217 D0 NO 20003217D0 NO 20003217 A NO20003217 A NO 20003217A NO 20003217 A NO20003217 A NO 20003217A NO 20003217 D0 NO20003217 D0 NO 20003217D0
- Authority
- NO
- Norway
- Prior art keywords
- carbazole
- fluorophenyl
- tetrahydro
- sulfonyl
- amino
- Prior art date
Links
- LDXDSHIEDAPSSA-OAHLLOKOSA-N Ramatroban Chemical compound N([C@@H]1CCC=2N(C3=CC=CC=C3C=2C1)CCC(=O)O)S(=O)(=O)C1=CC=C(F)C=C1 LDXDSHIEDAPSSA-OAHLLOKOSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19757983A DE19757983A1 (de) | 1997-12-24 | 1997-12-24 | Thermodynamisch stabile Form von (r)-3[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-0-propansäure (Ramatroban) |
| PCT/JP1998/005844 WO1999033803A1 (en) | 1997-12-24 | 1998-12-24 | Thermodynamically stable form of (r)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9h-carbazole -9-propanoic acid (ramatroban) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20003217D0 true NO20003217D0 (no) | 2000-06-21 |
| NO20003217L NO20003217L (no) | 2000-06-21 |
| NO316618B1 NO316618B1 (no) | 2004-03-08 |
Family
ID=7853457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20003217A NO316618B1 (no) | 1997-12-24 | 2000-06-21 | Termodynamisk stabil form av (R)-3-[[(4-fluorfenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-karbazol-9-propansyre (Ramatroban), samt fremgangsmåte og anvendelse derav |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US6362214B1 (no) |
| EP (1) | EP1051398B1 (no) |
| JP (2) | JP3817668B2 (no) |
| KR (1) | KR100586350B1 (no) |
| CN (1) | CN1140510C (no) |
| AR (1) | AR013803A1 (no) |
| AT (1) | ATE263152T1 (no) |
| AU (1) | AU744242B2 (no) |
| BG (1) | BG65024B1 (no) |
| BR (1) | BR9814496A (no) |
| CA (1) | CA2313230A1 (no) |
| CO (1) | CO4970800A1 (no) |
| DE (2) | DE19757983A1 (no) |
| DK (1) | DK1051398T3 (no) |
| ES (1) | ES2218874T3 (no) |
| GT (1) | GT199800198A (no) |
| HN (1) | HN1998000186A (no) |
| HU (1) | HUP0004432A3 (no) |
| ID (1) | ID25446A (no) |
| IL (1) | IL136278A (no) |
| IN (1) | IN192932B (no) |
| MY (1) | MY116312A (no) |
| NO (1) | NO316618B1 (no) |
| NZ (1) | NZ504741A (no) |
| PE (1) | PE20000115A1 (no) |
| PL (1) | PL341359A1 (no) |
| PT (1) | PT1051398E (no) |
| RU (1) | RU2220137C2 (no) |
| SI (1) | SI1051398T1 (no) |
| SK (1) | SK285109B6 (no) |
| TR (1) | TR200001936T2 (no) |
| TW (1) | TW552258B (no) |
| UA (1) | UA66832C2 (no) |
| UY (2) | UY25324A1 (no) |
| WO (1) | WO1999033803A1 (no) |
| ZA (1) | ZA9811817B (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2107907B1 (en) * | 2006-12-20 | 2012-02-01 | Cardoz AB | Combination of pemirolast and ramatroban for use in the treatment of inflammatory disorders |
| EP2104534A1 (en) * | 2007-01-16 | 2009-09-30 | Cardoz AB | New combination for use in the treatment of inflammatory disorders |
| WO2009007674A2 (en) * | 2007-07-11 | 2009-01-15 | Cardoz Ab | Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and ramatroban or seratrodast |
| WO2011115069A1 (ja) * | 2010-03-19 | 2011-09-22 | 第一三共株式会社 | 結晶の網羅的探索 |
| CN103054857A (zh) * | 2012-12-30 | 2013-04-24 | 北京阜康仁生物制药科技有限公司 | 一种以雷马曲班为活性成分的固体制剂 |
| ES2991300T3 (es) | 2015-02-13 | 2024-12-03 | Inserm Institut Nat De La Sante Et De Larecherche Medicale | Antagonistas de PTGDR-1 y/o PTGDR-2 para prevenir y/o tratar lupus eritematoso sistémico |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1557665A (en) * | 1975-12-10 | 1979-12-12 | Ici Ltd | Process for the manufacture of a carboxyalkylamino anthraquinone compounds |
| US4616028A (en) * | 1985-04-22 | 1986-10-07 | American Home Products Corporation | Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, compositions and use |
| DE3631824A1 (de) | 1986-02-21 | 1988-03-31 | Bayer Ag | Cycloalkano(1.2-b)indol-sulfonamide |
| CN1015711B (zh) | 1986-02-21 | 1992-03-04 | 拜尔公司 | 制备环烷并[1,2-b]吲哚-磺酰胺类化合物的方法 |
| GB8924392D0 (en) * | 1989-10-30 | 1989-12-20 | Bayer Ag | Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides |
| DE19506739A1 (de) | 1995-02-27 | 1996-08-29 | Bayer Ag | [3-Amino]-tetrahydrocarbazol-propansäureester |
-
1997
- 1997-12-24 DE DE19757983A patent/DE19757983A1/de not_active Withdrawn
-
1998
- 1998-12-09 HN HN1998000186A patent/HN1998000186A/es unknown
- 1998-12-11 AR ARP980106318A patent/AR013803A1/es unknown
- 1998-12-15 GT GT199800198A patent/GT199800198A/es unknown
- 1998-12-22 MY MYPI98005837A patent/MY116312A/en unknown
- 1998-12-22 PE PE1998001272A patent/PE20000115A1/es not_active Application Discontinuation
- 1998-12-23 CO CO98076459A patent/CO4970800A1/es unknown
- 1998-12-23 TW TW087121479A patent/TW552258B/zh not_active IP Right Cessation
- 1998-12-23 ZA ZA9811817A patent/ZA9811817B/xx unknown
- 1998-12-23 UY UY25324A patent/UY25324A1/es not_active IP Right Cessation
- 1998-12-24 US US09/582,250 patent/US6362214B1/en not_active Expired - Fee Related
- 1998-12-24 BR BR9814496-0A patent/BR9814496A/pt not_active Application Discontinuation
- 1998-12-24 NZ NZ504741A patent/NZ504741A/xx unknown
- 1998-12-24 DK DK98961506T patent/DK1051398T3/da active
- 1998-12-24 TR TR2000/01936T patent/TR200001936T2/xx unknown
- 1998-12-24 CA CA002313230A patent/CA2313230A1/en not_active Abandoned
- 1998-12-24 DE DE69822882T patent/DE69822882T2/de not_active Expired - Fee Related
- 1998-12-24 WO PCT/JP1998/005844 patent/WO1999033803A1/en not_active Ceased
- 1998-12-24 IL IL13627898A patent/IL136278A/xx not_active IP Right Cessation
- 1998-12-24 ES ES98961506T patent/ES2218874T3/es not_active Expired - Lifetime
- 1998-12-24 UA UA2000074335A patent/UA66832C2/uk unknown
- 1998-12-24 ID IDW20001226A patent/ID25446A/id unknown
- 1998-12-24 SK SK975-2000A patent/SK285109B6/sk unknown
- 1998-12-24 HU HU0004432A patent/HUP0004432A3/hu unknown
- 1998-12-24 RU RU2000119741/04A patent/RU2220137C2/ru not_active IP Right Cessation
- 1998-12-24 PL PL98341359A patent/PL341359A1/xx not_active Application Discontinuation
- 1998-12-24 IN IN43MU2000 patent/IN192932B/en unknown
- 1998-12-24 KR KR1020007007031A patent/KR100586350B1/ko not_active Expired - Fee Related
- 1998-12-24 PT PT98961506T patent/PT1051398E/pt unknown
- 1998-12-24 EP EP98961506A patent/EP1051398B1/en not_active Expired - Lifetime
- 1998-12-24 AU AU16874/99A patent/AU744242B2/en not_active Ceased
- 1998-12-24 SI SI9830656T patent/SI1051398T1/xx unknown
- 1998-12-24 CN CNB98812405XA patent/CN1140510C/zh not_active Expired - Fee Related
- 1998-12-24 AT AT98961506T patent/ATE263152T1/de not_active IP Right Cessation
- 1998-12-24 JP JP2000526487A patent/JP3817668B2/ja not_active Expired - Lifetime
-
1999
- 1999-06-18 UY UY25575A patent/UY25575A1/es unknown
-
2000
- 2000-06-21 NO NO20003217A patent/NO316618B1/no unknown
- 2000-06-23 BG BG104554A patent/BG65024B1/bg unknown
-
2005
- 2005-11-25 JP JP2005340586A patent/JP4411269B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO990059L (no) | Analoger av kationiske proteiner | |
| HUP9902136A3 (en) | Novel substituted cyclic amino acid derivatives use as pharmaceutical agents | |
| FI973085L (fi) | Menetelmä 1-(tiometyyli)syklopropaanietikkahapon valmistamiseksi | |
| AU3214897A (en) | Encapsulation of proprietary protocol information | |
| AU8511598A (en) | Cost based routing protocol | |
| AU5474996A (en) | Novel crystalline forms of anhydrous 7-{(1alpha,5alpha, 6alpha)-6-amino-3-azabicyclo(3.1.0)hex-3-y1}-6-fluoro-1- (2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3- carboxylic acid, methanesulfonic acid salt. | |
| DE59912915D1 (de) | Herstellung von 4,4'-Diketo-carotinoiden | |
| HUP9801089A3 (en) | Benzenesulfonamide derivatives, process for their preparation, pharmaceutical compositions containing them | |
| NO20003217D0 (no) | Termodynamisk stabil form av (R)-3-[[(4-fluorfenyl)- sulfonyl]amino]-1,2,3,4-tetrahydro-9H-karbazol-9-propansyre | |
| DE69814346D1 (de) | Herstellung von phosphatestern | |
| ZA975755B (en) | Useful formulations of acid addition salt drugs. | |
| BR9706942A (pt) | Método de transformação genética de árvores | |
| ATE227733T1 (de) | Herstellung von avermectin-verbindungen | |
| NO995388D0 (no) | Fremgangsmåte for fremstilling av formylfosfonsyre | |
| PT1133495E (pt) | Semi-hidrocloreto do acido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo-¬4.3.0|-nonano-8-il)-6-fluoro-1,4-diidro-4-oxo-3-quinolinocarboxilico | |
| AU4214800A (en) | Vesicle associated proteins | |
| DE69822338D1 (de) | Polyisobuten substituierte bernsteinsäureimide | |
| NO981499L (no) | FremgangsmÕte for fremstilling av titandioksyd | |
| AU8985298A (en) | Novel sulphonamide derived from substituted anilines useful as medicines | |
| AU1251399A (en) | N-alkylation of 5-amino-2,4,6-triiodo-isophthalamides | |
| HUP9800430A3 (en) | Novel benzenesulfonamide derivatives, process for preparing them and pharmaceutical compositions containing them | |
| AU2178999A (en) | Preparation of methacrylic acid, derivatives thereof or precursors thereto | |
| AU6163998A (en) | Human p24 vesicle proteins | |
| ITRM970049A1 (it) | Procedimento per la preparazione dell'acido 2-iodossibenzoico. | |
| IT1291675B1 (it) | Procedimento per la preparazione dell'acido 4,5-difenilossazol-2- propanoico |